Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000722603 | SCV004560488 | pathogenic | not provided | 2023-12-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gly315Alafs*28) in the SLC34A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC34A3 are known to be pathogenic (PMID: 16358214, 16358215, 22159077). This variant is present in population databases (no rsID available, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with nephrolithiasis (PMID: 34721296). ClinVar contains an entry for this variant (Variation ID: 591424). For these reasons, this variant has been classified as Pathogenic. |
Gharavi Laboratory, |
RCV000722603 | SCV000853734 | uncertain significance | not provided | 2018-09-16 | no assertion criteria provided | research |